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ttp://dx.doi.org/10.1016/j.ajpath.2014.05.010Autophagy plays an essential role in maintaining an intricate balance between nutrient demands and
energetic requirements during normal homeostasis. Autophagy recycles metabolic substrates from
nonspeciﬁc bulk degradation of proteins and excess or damaged organelles. Recent work posits an
active and dynamic signaling role for extracellular matrix-evoked autophagic regulation, that is, allo-
steric and independent of prevailing nutrient conditions. Several candidates, representing a diverse
repertoire of matrix constituents (decorin, collagen VI, laminin a2, endostatin, endorepellin, and
kringle V), can modulate autophagic signaling pathways. Importantly, a novel principle indicates that
matrix constituents can differentially modulate autophagic induction and repression via interaction
with speciﬁc receptors. Most of the matrix-derived factors described here appear to control autophagy
in a canonical manner but independent of nutrient deprivation. Because the molecular composition and
structure of the extracellular matrix are dynamically remodeled during various physiological and
pathological conditions, we propose that matrix-regulated autophagy is key for maintaining proper
tissue homeostasis and disease prevention, such as cancer progression and muscular dystrophies.
(Am J Pathol 2014, 184: 2146e2153; http://dx.doi.org/10.1016/j.ajpath.2014.05.010)Supported by NIH grants RO1 CA39481, RO1 CA47282, and RO1
CA164462 (R.V.I.) and the German Research Council SFB 815,
project A5, SFB 1039, project B2, and Excellence Cluster ECCPS
(L.S.).
Disclosures: None declared.Macroautophagy (hereafter known as autophagy) is a cata-
bolic process that nonselectively degrades bulk cytosolic
components, proteins, and organelles, recycling liberated
nutrients for the synthesis of new macromolecules.1,2 Auto-
phagic induction occurs via the reduced availability of
nutrients. Intrinsically, autophagic initiation is a tightly co-
ordinated and regulated process, involving the suppression of
nascent peptide synthesis [via suppression of phosphoinosi-
tide 3-kinase (PI3K)/Akt/mammalian target of rapamycin
(mTOR) arm] and activation of the forkhead box subclass O3
(FoxO3) transcription factor that promotes recruitment of
Vps34, a class III PI3K, to beclin 1-positive complexes.3,4
Autophagy is linked to prevailing energetic demands, over-
all cellular metabolome, and cell growth programs.
The modulation of autophagy is emerging as a frontrunner in
curtailing several diseases, including tumorigenesis5 andstigative Pathology.
.muscular dystrophies.6 The classiﬁcation of autophagy as a
tumor suppressive entity7,8 further aligns with the amply docu-
mented function of soluble matrix constituents, such as decorin
and endostatin, as oncostatic and angiostatic effectors.9,10
Moreover, autophagy is gaining acceptance as a necessary
prerequisite in maintaining tissue integrity and overall organ-
ismal homeostasis.11e13 Aberrant autophagy, deﬁned by either
inadequate levels or hyperactive autophagic ﬂux, is detrimental
for normal tissue function and manifests as neurological disor-
ders such as Parkinson disease14 or congenital myopathies.6
Matrix Regulates AutophagyMatrix-derived signals transduced from receptor engage-
ment converge on a common core of autophagic machinery
in a variety of tissues and specialized microenvironments and
are necessary for germane biological phenotypes. A diverse
collection of matrix constituents, including decorin, collagen
VI, laminin a2, endostatin, endorepellin, and kringle V, are
rapidly emerging as regulators of autophagy that are seem-
ingly independent of the predominant nutrient concentra-
tions. Although the concept of extracellular matrix (ECM)
regulation of autophagy has been discussed before,15 most of
the previous studies focused on how detachment from the
matrix (anoikis) would trigger autophagy, primarily through
an integrin-mediated mechanism. In this review, we focus on
soluble, matrix-derived products with an intrinsic ability to
modulate catabolic metabolism. We propose that the ECM is
a functional repository of autocrine and paracrine factors that
dynamically modulate, couple, and wield autophagy as a
potent tumor suppressor and function prominently in the
prevention of several complex pathological states.Decorin Evokes Autophagy and Mitophagy
Decorin Regulates Oncogenes and Tumor Suppressor
Genes
Decorin, with the proposed title of guardian from the matrix,
is a pan-receptor tyrosine kinase (RTK) inhibitor for
tumorigenic and angiogenic suppression.10,16 It binds RTK
members via its protein core, concurrently elicits degrada-
tion, and attenuates downstream signaling.10 Decorin sup-
presses critical oncogenes (b-catenin, Myc, and hypoxia
inducible factor-1a) and simultaneously induces tumor
suppressor genes (p21, thrombospondin-1, and mitostatin)
that oppose oncogenesis and angiogenesis.17,18 Moreover,
decorin coordinates a pro-inﬂammatory cascade function in
sepsis and tumorigenesis.19
Decorin Induces Peg3 Expression
A paradigm shift has occurred about the bioactivity of
decorin after high-resolution transcriptome proﬁling of theThe American Journal of Pathology - ajp.amjpathol.orgtumor microenvironment.20 Systemically administered
decorin evokes a stromal-speciﬁc gene signature. Among
the small subset of induced genes, decorin stimulates the
expression of a putative tumor suppressor gene Peg3.20 By
exploiting the genomically stable nature of endothelial cells
as a surrogate for a crucial component of the tumor
microenvironment, paternally expressed 3 (Peg3) immuno-
staining with established autophagic markers has indicated
the formation of subcellular structures reminiscent of
autophagosomes.21
Mechanistically, decorin engages vascular endothelial
growth factor 2 (VEGFR2) for Peg3 redistribution on the
autophagosomal membrane, concomitant with autophago-
some formation in contrast to control conditions (Figure 1,
A and B). Paramount with these observations is the
requirement of Peg3 in maintaining basal BECN1 levels.
Further, silencing Peg3 abrogates decorin-mediated induc-
tion of autophagic genes downstream of VEGFR221
(Figure 2). Concurrently, mitochondrial membrane poten-
tial and capillary morphogenesis are disrupted.21
Despite Peg3 being classiﬁed as a krupple-type zinc ﬁnger
transcription factor, Peg3 is not observed within the nuclear
compartment of endothelial cells, as shown for neural pro-
genitors.22 Because the architecture of zinc ﬁnger domains
permits high-afﬁnity RNA or DNA binding, Peg3 may bind
mature BECN1 mRNA for protection, stability, and/or
enhanced translation for rapid synthesis. This scenario is
congruent with the rapid kinetics of decorin-evoked autophagic
induction. Further, despite decorin inducingPeg3 expression in
mammary ﬁbroblasts cocultured with triple-negative breast
carcinoma cells,20 transcriptional inductionwithmacrovascular
and microvascular endothelial cells is not achieved. Therefore,
it remains plausible that decorin directly stabilizes Peg3 via as-
of-yet deﬁned post-translational modiﬁcations.Decorin Is a Partial Agonist of VEGFR2
Molecular dissection of the downstream signaling apparatus
reveals that decorin rapidly activates AMP-activated protein
kinase, a master energy sensor and pro-autophagic ki-
nase,23,24 downstream of VEGFR2 signaling25 (Figure 2).Figure 1 Induction of endothelial cell autophagy by
various soluble extracellular matrix constituents. Confocal
images of human umbilical vein endothelial cells treated for
6 hours with vehicle (A) or with either 200 nmol/L human
recombinant decorin (B) or 200 nmol/L human recombinant
endostatin (C). Notice the presence of numerous autophagic
vacuoles immunolabeled by antibodies against beclin 1 (red)
and LC3 (green) after merging of the two ﬂuorophores.
Nuclei are stained in blue with DAPI. D: Immunoﬂuorescence
image of human umbilical vein endothelial cells treated with
200 nmol/L human recombinant endorepellin for 6 hours and
stained with an antibody against LC3. The images were
captured under differential interference contrast microscopy
and show large autophagosomes stained by LC3. Scale barZ
10 mm (AeD).
2147
Figure 2 Categorically, the regulatory matrix
entities segregate into two functionally distinct
classes, activators (decorin, collagen VI, kringle 5,
and endostatin) and inhibitor (laminin a2).
Binding of each discrete molecule to a cognate
receptor permits a multitude of signaling cascades
that terminate on shared autophagic components.
Cell- and tissue-speciﬁc modulation of this com-
mon core (Peg3, beclin 1, and LC3) ultimately
dictates a pro- or anti-autophagic response. Please
see text, where indicated, for complete pathway
analyses. P-APMK, phosphorylated adenosine 50-
monophsophate-activated protein kinase.
Neill et alDeciphering the complex regulatory network reveals that
decorin suppresses anti-autophagic effectors (Akt, mTOR,
p70S6K) while simultaneously evoking the physical and
recombinatorial association of Bcl-2, beclin 1, and Vps3425
Decorin-induced association of beclin 1/Vps34 complexes
and the concurrent disengagement of the autophagic inhib-
itor Bcl-2 further reinforce a dynamic network for auto-
phagic initiation that is wholly coordinated by an ECM
constituent.25 These ﬁndings reveal a new function for
decorin. Because decorin requires the VEGFR2 kinase for
downstream autophagic induction, the view of decorin as
strictly an RTK inhibitor erodes; decorin does indeed
function as a partial agonist of VEGFR2 and a modulator of
a novel master regulator of autophagy, Peg3, which controls
beclin 1 and LC3 expression.
Decorin Attenuates EGFR and Downstream Effectors
Decorin has an avid proclivity for attenuating epidermal
growth factor receptor (EGFR) and downstream effectors.
Notably, a recent study indicates that EGFR and Akt
phosphorylate beclin 1, inactivating autophagic progression
and promoting tumorigenesis.26,27 Attenuation of EGFR and
Akt signaling by decorin28 represents a viable signaling
pathway for autophagic induction in cancer cells. Decorin
exerts its anti-oncogenic activities indirectly via endothelial
autophagy and directly by attenuating the angiogenicity of
the tumor proper. Moreover, decorin functions as a partial
agonist of Met and evokes tumor cell mitophagy in mam-
mary carcinoma cells.29
By dynamically regulating peroxisome proliferator-
activated receptor-g coactivator-1a, stabilized mitostatin
mRNA permits accumulated mitostatin and mitophagic in-
duction independent of beclin 1 (Figure 2).29 Crucially, loss2148of mitostatin abrogates canonical mitophagic stimuli (rapa-
mycin and nutrient deprivation) and decorin-evoked
mitophagy.29 These observations deﬁne mitostatin as a
novel and fundamental mitophagic effector. Importantly,
failure of mitophagic induction prevents decorin from sup-
pressing vascular endothelial growth factor Aemediated
angiogenesis. Thus, mitostatin (and mitophagic initiation) is
critical for decorin-mediated angiostasis.29
Autophagic induction may represent a general phenom-
enon for related SLRP members. Decorin may represent a
novel class of matrix components that are released for
autophagic induction after a pathological insult. A recent
study indicates that FoxD1 transcriptionally represses Dcn
expression.30 Derepression of Dcn via inactivation of
FoxD1 would stimulate pro-autophagic processes mediated
by decorin. FoxD1 may be downstream of anti-autophagic
PI3K/Akt/mTOR effectors, or may be directly antagonized
by the pro-autophagic AMP-activated protein kinase
pathway. Thus, soluble decorin elicits autophagy within the
stroma and mitophagy within the tumor and is postulated as
a soluble factor for tumorigenic and angiogenic suppression.
The Matrix Evokes Autophagy for Cancer
Suppression
Role of Autophagy in Cancer
The role of autophagy in modulating tumorigenesis
currently subsumes a dichotomous function by either pro-
moting or restricting progression, although the precise
function of autophagy in cancer remains unknown.31
However, the critical importance of autophagy operating
within the initial stages of tumorigenic development is
rapidly becoming evident.32 Data support the existence of aajp.amjpathol.org - The American Journal of Pathology
Matrix Regulates Autophagycommon core of signaling pathways that are responsible for
regulating cell proliferation, angiogenesis, cell growth, and
apoptosis that are subverted for controlling autophagy
throughout malignant transformation.32 Several opportu-
nities for clinical intervention and novel chemotherapeutic
targets (eg, mTOR, tuberous sclerosis 2, beclin 1) for
modulating autophagy have come into focus.32
Role of Autophagy in Tumorigenesis
Hyperactive PI3K/Akt/mTOR/p70S6K signaling with the
consequent activation of Ras via a class I PI3K typiﬁes many
solid tumors, including breast, lung, liver, and prostate car-
cinomas.31 Collectively, the above signaling cascades inhibit
autophagic progression and function while simultaneously
driving cancer in a growth factoredependent manner.32
Moreover, the down-regulation of autophagy (and to a
larger extent, specialized autophagy, such as chaperone
mediated and mitophagy) is associated with and considered
necessary for competent tumorigenesis.31
Metabolically, the stimulation of proliferation, migration,
and metastasis strictly relies on various anabolic processes
for macromolecule assembly. Conversely, as a whole, auto-
phagy is a catabolic process that seemingly opposes molec-
ular and biochemical synthesis.32 Furthermore, in the context
of growth factor signaling, stimulatory ligands regulate
glucose and amino acid inﬂux and production, respectively,
both of which are potent autophagic inhibitors.33
Autophagy in Cancer Therapeutics
Stimulation of autophagy compromises several aspects of
continued tumorigenic growth such as immune-evasion and
angiogenesis.33 Intriguingly, speciﬁc classes of antineo-
plastic chemotherapeutics (eg, anthracyclines and oxalipla-
tin) trigger immunogenic cell death.34 Importantly, these
drugs require and depend on autophagic induction.34 Tumors
experiencing autophagy recruit T lymphocytes and antigen-
presenting dendritic cells directly into the tumor paren-
chyma.34 Moreover, pharmacological agents that suppress
the anti-autophagic mTOR signaling cascade (eg, rapamycin)
suppresses angiogenesis in various mouse models.33
Autophagic induction is directly relevant for chemother-
apeutic efﬁcacy and tumor responsiveness.31,35 However,
predictions for patient response to cancer therapeutics are
compounded by our limited knowledge on forecasting
autophagic ﬂux in vivo in response to the stimulus.35 As
such, four distinct forms of autophagy have been identiﬁed,
cytoprotective, cytostatic, cytotoxic, and nonprotective,35
each offering unique cellular viability responses to chemo-
therapeutic agents.
ECM molecules that function as autophagic inducers
counteract growth factor signaling and suppress anti-
autophagic signaling relays in favor of pro-autophagic out-
comes (via Vps34). Intriguingly, decorin suppresses class I
PI3K/mTOR signaling in physiologically normal endothelialThe American Journal of Pathology - ajp.amjpathol.orgcells, leading to autophagic programs.21 Moreover, decorin
elicits mitophagy in tumor cells.29 Collectively, induction by
decorin (and related autophagic matrikines) may represent a
mechanism for tumorigenic and angiogenic suppression or
for quelling homeostatic imbalances relevant for human pa-
thologies (ie, muscular dystrophies). These functions may
depend on the form of autophagy evoked and in the patho-
logical microenvironment by which it is evoked.Collagen VI Is Required for Maintaining
Skeletal Muscle Homeostasis via Autophagy
Collagen VI Distribution and Function
As a major structural constituent of the ECM, collagen VI is
widely distributed and highly expressed in multiple tissues,
including skin, cornea, adipose tissue, lung, brain, nerves,
blood vessels, intervertebral disks, and skeletal muscle.36
Collagen VI forms a lattice composed of beaded microﬁl-
aments that mediate a plethora of proteineprotein in-
teractions that provide structural support within the local
microenvironment for the surrounding tissues.36 However,
collagen VI promotes and regulates active signaling pro-
cesses for a variety of cell functions, including proliferation,
angiogenesis, apoptosis, tumorigenesis,36 and maintaining a
stem cell niche for satellite cell renewal and muscle
regeneration.37Collagen VI Maintains Skeletal Muscle Homeostasis
Collagen VI is a major ECM protein localized within the
endomysium of skeletal muscle and is chieﬂy responsible for
regulating muscle cell homeostasis and function.6 Balancing
anabolic and catabolic processes in skeletal muscle is
essential for achieving homeostasis. A prime mechanism for
ensuring an appropriate response from skeletal muscle during
times of physiological activity, stress, and exercise occurs via
autophagy.6,38 The importance of autophagy is underscored
by the ﬁndings that defective or hyperactive autophagic re-
sponses are ultimately detrimental for skeletal muscle and
often manifest as muscle dystrophies.6,39
Recently, maintaining autophagy in skeletal muscle has
been linked to proper collagen VI structure, expression, and
function.38,40 Several congenital muscular dystrophies,
including Bethlem myopathy and Ullrich congenital muscular
dystrophy, have been causatively associated with mutations in
the genes that encode the three chains of collagen VI.40 For
instance, deﬁciencies of collagen VI trigger morphological
aberrations in the ultrastructure of mitochondria and sarco-
plasmic reticulum.41 Further, muscle ﬁber death via activation
of the intrinsic apoptotic cascade occurs spontaneously in
myopathic mice with collagen VI deﬁciency (Col6a1/).41
Combined, both abnormalities precede and result in myo-
ﬁber failure and degeneration while presenting clinically as a
collagen VI-type muscular dystrophy.2149
Neill et alInterrogating themolecular underpinnings of this phenotype
reveals impaired autophagic induction and ﬂux in Col6a1/
mice.40 Indeed, skeletal muscle from Col6a1/mice exhibits
compromised Akt/FoxO3 signaling, increased-activated pro-
tein kinase activation, lower amounts of lipidated LC3, and
decreased autophagosome formation, indicating an energy
anomaly concomitant with decreased basal autophagy.40
Further, Bnip3 and beclin 1, two key effectors of mitochon-
drial removal42 and autophagic induction,4 respectively, are
disproportionately deregulated inCol6a1/ skeletal muscle40
(Figure 2). Restoration of beclin 1 activity or dietary restriction
in Col6a1/ mice reactivates autophagy and ameliorates the
dystrophic phenotype.40 Moreover, pharmacological modu-
lation of key targets, such as the autophagic inhibitor mTOR,
with either rapamycin or cyclosporin A diminishes myoﬁber
degeneration, promotes the turnover of malfunctioning or-
ganelles, and reinstates normal mitochondrial function by re-
establishing physiologically relevant levels of Bnip3 and
beclin 1.40
Collagen IV and Decorin May Function as an
Outside-In Pro-Autophagic Complex
Functionally, collagen VI is an autophagic inducer and prime
regulator for skeletal muscle that circumvents muscular
dystrophies by ﬁne-tuning the autophagic ﬂux that is optimal
for functional myoﬁbers. Soluble decorin, which engages
VEGFR2 for endothelial cell autophagy and Met for tumor
cell mitophagy, is a canonical collagen VI binding partner.10
Thus, decorin-bound collagen VI may act synergistically for
regulatory control of autophagic initiation within the myo-
ﬁber microenvironment. Notably, the C-terminal portion of
collagen VI interacts with tumor endothelial marker 8.43
Because tumor endothelial marker 8 physically interacts
with VEGFR2, it is possible that collagen VI might also
induce autophagy in endothelial cells by using these two
receptors. Moreover, the colocalization and physical inter-
action of decorin and collagen VI, together with the potential
use of common receptors and core signaling pathways,
suggests that these two matrix constituents are part of an
outside-in signaling network that controls intracellular
catabolism via autophagic induction and modulation.
Basement Membrane Laminin a2 Functions as
an Endogenous Autophagic Inhibitor
In contrast to the pro-autophagy molecules discussed in the
previous section, the laminin a2 chain subsumes a unique
position insofar as it has anti-autophagic properties.44 Lam-
inin a2 comprises the a2 subunit of laminin 211, a key
basement membrane component. Mutations in the a2 subunit
cause merosin-deﬁcient congenital muscular dystrophy
(MDC1A), a progressive muscular dystrophy characterized
by muscle weakness due to generalized skeletal muscle at-
rophy, peripheral neuropathy, and joint contractures.39,442150In contrast to collagen VI-mediated autophagic induction,
loss of LAMA2, which encodes the laminin a2 subunit,
causes increased expression of autophagy genes44 (Figure 2).
Among the up-regulated genes are FOXO3, a pioneer tran-
scription factor involved in regulating autophagy genes,
BECN1, MAPLC3B, and p62/SQSTM1.44 Interestingly,
MDC1A myotubes have induced protein levels of Vps34,
beclin 1, LC3, and cathepsin L.44 The cysteine protease
cathepsin L liberates endorepellin, the angiostatic C-terminus
of perlecan, a major basement membrane constituent.45
In analogy with the pharmacological (rapamycin) rescue
of deﬁcient autophagy on loss of collagen VI in Bethlem
myopathy and Ullrich congenital muscular dystrophy, sys-
temic delivery of 3-methyladenine, a Vps34 inhibitor, re-
stores autophagy gene expression programs and normalizes
MDC1A skeletal muscle.4,44 As tissue morphology im-
proves, the regenerative capacity of the muscle is stimulated
and overall survival increases.4,44 Further, the phosphory-
lation of Akt, an autophagic inhibitor that simultaneously
activates mTOR and attenuates the pro-autophagic FoxO3
forkhead transcription factor, phenocopies (eg, diminished
phosphorylation at Thr308 and Ser476) wild-type litter-
mates.44 Therefore, basement membranes are composed of
functionally opposite members that can ﬁne-tune autophagic
induction in a temporal and spatial manner.
Endostatin, Endorepellin, and Kringle 5 Evoke
Endothelial Cell Autophagy and Apoptosis
Endostatin
The proteolytically processed C terminus of collagen XVIII-
a1 yields a potently angiostatic module known as endo-
statin, which mediates antiproliferative and antimigratory
effects. Through high-afﬁnity interactions with the a5b1
integrin, soluble endostatin induces endothelial cell auto-
phagy in multiple models46,47 and human umbilical vein
endothelial cells (Figure 1C). Thus, endostatin could be also
considered as a unique member of pro-autophagic members.
Moreover, a mutated form of endostatin (P125A endostatin)
that exhibits higher afﬁnity binding and enhanced inhibitory
effects evokes autophagy in a Vps34/beclin 1/LC3-
dependent manner46,47 (Figure 2). Autophagosome nucle-
ation and maturation are pharmacologically inhibited by
3-methyladenine treatment in the presence of P125A
endostatin,47 suggesting that, as with decorin, a canonical
pathway is followed. In accordance with increased differ-
ential binding of beclin 1 with pro-autophagic effectors and
simultaneous disengagement from anti-autophagic partners,
both Bcl-2 and Bcl-xL are reduced.
47 Further, in analogy to
decorin, endostatin suppresses Wnt/b-catenin signaling
concurrent with decreased b-catenin levels.47 Functionally,
b-catenin opposes beclin 1 signaling,47 underscoring the
biological relevance of b-catenin suppression for autophagic
induction in endothelial cells downstream of the a5b1
integrin for effective anti-angiogenic properties.47ajp.amjpathol.org - The American Journal of Pathology
Matrix Regulates AutophagyEndorepellin
Proteolytically released endostatin from the collagenXVIII-a1
chain and ensuing endothelial cell autophagy may represent a
general mechanism for processed basementmembrane heparin
sulfate proteoglycans. Perlecan, a major heparin sulfate pro-
teoglycan of cell surfaces and vascular basement membranes,
may be processed for endorepellin release, resulting in
angiostasis and endothelial cell autophagy, downstream of
simultaneous ligation of VEGFR2 and the a2b1 integrin.48
Indeed, endorepellin stimulates autophagy in endothelial
cells (Figure 1D) downstream of VEGFR2 in a Peg3-
dependent manner.49 Notably, endorepellin promotes auto-
phagy via the ﬁrst two laminin-like globular domains LG1/2,
whereas the terminal LG3 domain interacts with the a2b1
integrin to induce dissolution of actin cytoskeleton.49
Kringle 5
Kringle 5, an internal domain of plasminogen, can induce
endothelial cell autophagy via GRP78 (glucose-regulated
protein, 78 kDa) another cell surface-expressed receptor.50
Kringle 5 evokes autophagy in a beclin 1-dependent manner
via differential binding to the Bcl-2/beclin 1/Vps34 complex50
(Figure 2). Concurrent with autophagic induction, Kringle 5
also evokes the intrinsic apoptotic cascade via potentiation of
caspase-3/-7 activity.50 It is probable that mitochondrial
insufﬁciency via increased autophagy is responsible for
apoptotic induction. Notably, soluble decorin and endostatin
increase plasminogen expression.51,52 Thus, these established
and multifunctional agents might induce expression of addi-
tional members of the autophagic cell machinery.
A universally recurring theme shared among decorin,
collagen VI, endostatin, endorepellin, and kringle 5 involves
the convergence of pro-autophagic signals onto a common
core of autophagic effectors, including Vps34, beclin 1, and
lipidated LC3 (Figure 2). Despite signaling from a diverse
array of receptors, soluble pro-autophagic molecules engage
a common set of relays for endothelial autophagy. The
recent identiﬁcation of Peg3 as an autophagic kingpin21 may
represent a common mode for autophagic signaling and
recruitment of the downstream transduction apparati.
Perspectives
Regulatory networks that govern autophagic induction,
maintenance, and termination are rapidly being uncovered
as key cellular mechanisms for a variety of processes,
including metabolism, growth, proliferation, differentiation,
genome stability, and apoptosis. Because intracellular
checkpoints and supramolecular complexes responsible for
executing autophagy are being elucidated, signals derived
from the extracellular milieu are beginning to be more
appreciated. The ECM, as a whole, is undergoing a para-
digmatic shift that not only provides structural cues for cells
and tissues but also actively functions as a signaling hub thatThe American Journal of Pathology - ajp.amjpathol.orgdictates cell behaviors, identities, and phenotypes. This
critical role is executed by matrikines and is exempliﬁed in
the scenario of EGFR regulation.53 A multitude of matri-
cellular proteins act as either endogenous activators (tenas-
cin C, laminin 322, secreted protein acidic and rick in
cysteine, thrombospondin, osteopontin, and ﬁbulins) or in-
hibitors (decorin) that spatially and temporally modulate
EGFR signaling plasticity.53
The most established pan-RTK inhibitor and potent
tumoricidal agent, decorin, is once again a harbinger for a
novel regulatory archetype that embodies a potentially new
class of matrix molecules. Autophagy may represent the
underlying and unifying mechanism for defending against
tumor and disease progression. A new category of matri-
kines has emerged that differentially modulate autophagic
ﬂux in a wide variety of cell and tissue microenvironments.
Importantly, decorin, collagen VI, endostatin, endorepellin,
and kringle 5 represent pro-autophagic matrix constituents
that engage a diverse array of cell surface receptors for
autophagic initiation. However, the laminin a2 chain acts as
an endogenous autophagic inhibitor.44 Absence of laminin
a2 permits excessive autophagy and yields a progressive
muscular dystrophy that is suppressed by pharmacological
agents.44 Collectively, these matrix members provide a
molecular counterweight for maintaining and activating
autophagy that is requisite for preventing and combating
disease progression (eg, cancer, neurodegeneration, and
muscular dystrophies). This unique class of matrix mole-
cules can function as a safeguard against inappropriate and
hyperactive autophagy (as seen in MDC1A) that, if un-
checked, can manifest as homeostatic abnormalities.
Decorin-mediated autophagic induction of endothelial
cells occurs via a Peg3/beclin 1/LC3-mediated pathway,21,54
analogous to the role that beclin 1 and LC3 have for
endostatin-, collagen VI-, and kringle 5-mediated autopha-
gosome formation.40,47,50 However, decorin-evoked tumor
cell mitophagy progresses in a beclin 1-independent manner
but relies on a new general mitophagic effector, mitosta-
tin.29 Interestingly, endothelial cells appear exquisitely
sensitive because decorin, endostatin, endorepellin, and
kringle 5 evoke autophagy and/or apoptosis. Autophagic
induction by these soluble matrix constituents plays a crit-
ical role in suppressing tumor angiogenesis.
A key tenet of pro-autophagic activity is the requirement of
positive signaling via RTKs, integrins, and coreceptors for the
protracted suppression of the anti-autophagic PI3K/Akt/mTOR
pathway.23 Attenuated PI3K/Akt/mTOR signaling, with
simultaneous-activated protein kinase activation, alleviates Bcl-
2 inhibition of beclin 1,13 beclin 1/LC3/Peg3 binding,21 and
FoxO3.3 Intriguingly, de-repression and consequent stabiliza-
tion of FoxO3 downstream of Akt effectively transactivates
several pro-autophagic loci.3,44,55 It is plausible that FoxO3 and
Peg3 may physically assemble and synergize at proximal pro-
moters of autophagy genes for induction by autophagic stimuli.
FoxO3 and Peg3 may directly target these specialized matrix
elements such as decorin and collagen VI, for transcriptional2151
Neill et alactivation, resulting in sustained autophagic signaling. More-
over, ligand binding to cognate receptors may stimulate further
expression of FoxO3 and Peg3, thereby constituting a positive
feed-forward loop. Analysis of endogenous autophagic in-
hibitors, such as Rubicon,1 has not yet been performed.
Matrikine-regulated autophagy may differentially affect
endogenous inhibitors (eg, laminin a2 and Rubicon) for feed-
back inhibition and autophagic cessation. Moreover, a recent
study has identiﬁed a chromatin switch mediated by hMOF
histone acetyltransferase at H4K16 that dictates the outcome of
autophagic signaling.56 Thus, matrix-derived signals might
directly inﬂuence this epigenetic switch in the decision of
autophagy-evoked cell death.
Conclusions
We have critically evaluated the role of several novel can-
didates for autophagic regulation. The aggregated themes
discussed distill into a new theory about matrix signaling
and the resulting effect on intracellular processes for disease
prevention. These members bind either one or multiple
signaling receptors and perhaps include coreceptors for
signal transduction, acting as partial agonists for down-
stream autophagic activation. Moreover, the molecular
proﬁle of the matrix dictates a microenvironment-speciﬁc
autophagic response. Thus, autophagic regulation further
reinforces the idea of matrix-based therapeutics as novel
modalities for combating a range of pathologies. We predict
that in the near future other ECM products will be found to
possess the biological function of affecting intracellular self-
eating and modulating catabolic metabolism.Acknowledgment
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